Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.008 AUD | 0.00% | -11.11% | 0.00% |
04-10 | Patrys Reports 'Positive' Results for Deoxymabs in Autoimmune Vasculitis Treatment | MT |
02-23 | Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 10
Sales per Business
AUD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical Research and Development
100.0
%
| 1 | 100.0 % | 3 | 100.0 % | +149.08% |
Sales per region
AUD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 1 | 100.0 % | 3 | 100.0 % | +149.08% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Campbell
CEO | Chief Executive Officer | - | 11/11/14 |
Chief Tech/Sci/R&D Officer | - | 31/05/12 | |
Rebecca Tunstall
PRN | Corporate Officer/Principal | - | 15/05/22 |
Stefan Ross
SEC | Corporate Secretary | - | 28/10/21 |
Deanne Greenwood
PRN | Corporate Officer/Principal | - | 31/12/07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Pamela Klein
BRD | Director/Board Member | 63 | 30/09/19 |
James Campbell
CEO | Chief Executive Officer | - | 11/11/14 |
Michael Stork
BRD | Director/Board Member | - | 18/02/07 |
Chairman | - | 15/11/22 | |
Stefan Ross
SEC | Corporate Secretary | - | 28/10/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,055,750,236 | 1,424,510,943 ( 69.29 %) | 0 | 69.29 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
0.00% | 10.88M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- PAB Stock
- Company Patrys Limited